Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
05/2012
05/02/2012CN101065363B Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms)
05/01/2012US8168833 Schwartz reagents: methods of in situ generation and use
05/01/2012US8168827 Amide derivative
05/01/2012US8168787 Process for the preparation of imatinib and intermediates thereof
05/01/2012US8168659 1, 5-diphenyl-3-benzylamino-1, 5-dihydropyrrolidin-2-one as CB1 receptor modulators
05/01/2012US8168653 Mediators of hedgehog signaling pathways, compositions and uses related thereto
05/01/2012US8168640 Cosmetic use of 1-aroyl-N-(2-oxo-3-piperidinyl)-2-piperazine carbomamides and related compounds
05/01/2012US8168639 Heterotricyclic compounds as serotonergic and/or dopaminergic agents and uses thereof
05/01/2012US8168627 Helix 12 directed non-steroidal antiandrogens
05/01/2012US8168615 Prodrugs of piperazine and substituted piperidine antiviral agents
05/01/2012US8168307 Organic compound, charge transport material and organic electroluminescent device
05/01/2012US8168052 Transition metal complexes with bidentate ligand having an imidazole ring
05/01/2012CA2698384C 3-pyridyl enantiomers and their use as analgesics
05/01/2012CA2545307C Substituted dihydroquinazolines ii
05/01/2012CA2517888C Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient
05/01/2012CA2509413C Benzazepine derivatives for the treatment of neurological disorders
05/01/2012CA2490722C Novel benzimidazole derivatives
05/01/2012CA2439604C N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation
04/2012
04/26/2012WO2012054333A2 Methods for identifying inhibitors of abeta42 oligomers
04/26/2012WO2012053630A1 Antagonist for mutated androgen receptor
04/26/2012WO2012053606A1 Arylaminoheterocyclic carboxamide compound
04/26/2012WO2012053186A1 Arylamide derivatives as ttx-s blockers
04/26/2012WO2012052948A1 Pyridine- 2- derivatives as smoothened receptor modulators
04/26/2012WO2012052540A1 Selective cyp11b1 inhibitors for the treatment of cortisol dependent diseases
04/26/2012WO2012052491A2 1-(heterocyclic carbonyl)-2-substituted pyrrolidines
04/26/2012WO2012052490A1 N-benzyl heterocyclic carboxamides
04/26/2012WO2012052489A1 1-(heterocyclic carbonyl) piperidines
04/26/2012WO2012052459A1 Pyrazole compounds acting against allergic, inflammatory and immune disorders
04/26/2012WO2012052451A1 Metabotropic glutamate receptor modulators
04/26/2012WO2012052420A1 Method for preparing substituted n-(3-amino-quinoxalin-2-yl)-sulfonamides and their intermediates n-(3-chloro-quinoxalin-2-yl)sulfonamides
04/26/2012WO2012052412A1 Novel heterocyclic compounds as pesticides
04/26/2012WO2012052410A1 Novel substituted picolinic acids, salts and acid derivatives thereof, and use thereof as herbicides
04/26/2012WO2012052377A1 Sterically hindered amine light stabilizers with mixed functionalization
04/26/2012WO2012052372A1 Tetrahydroquinoline derivatives used as ampk activators
04/26/2012WO2012052167A1 Substituted 6-amino-nicotinamides as kcnq2/3 modulators
04/26/2012WO2012051659A1 Viral polymerase inhibitors
04/26/2012WO2012024670A3 Composition and methods for treating glioblastoma
04/26/2012WO2012002680A3 2-pyridyl substituted imidazoles as therapeutic alk5 and/or alk4 inhibitors
04/26/2012WO2011155793A3 Pharmaceutical composition comprising amide derivative or pharmaceutically acceptable salt thereof
04/26/2012WO2009137651A3 Fungicidal substituted azoles
04/26/2012US20120101287 Amino-1,3,5-triazines N-substituted with chiral bicyclic radicals, process for their preparation, compositions thereof, and their use as herbicides and plant growth regulators
04/26/2012US20120101261 Use of multi-kinase inhibitors in the treatment of vascular hyperpermeability
04/26/2012US20120101133 Process for preparing tetrazole-substituted anthranilamide derivatives and novel crystal polymorphs of these derivatives
04/26/2012US20120101132 New Substituted Oxindole Derivative
04/26/2012US20120101131 Aminotetrahydroindazoloacetic Acids
04/26/2012US20120101116 Substituted heterocyclic compounds as kinases inhibitors and methods of use thereof
04/26/2012US20120101105 Aryl substituted carboxamide derivatives as calcium or sodium channel blockers
04/26/2012US20120101100 Heterocyclic urea derivatives and methods of use thereof-211
04/26/2012US20120101099 Histone deacetylase inhibitors
04/26/2012US20120101080 Composition for treatment of tuberculosis
04/26/2012US20120101079 Substituted 6-amino-nicotinamides as kcnq2/3 modulators
04/26/2012US20120101078 Amide derivatives as neuropeptide y5 receptor ligands
04/26/2012US20120101064 Imidazole derivatives and their use as modulators of cyclin dependent kinases
04/26/2012US20120100990 4 -aminopicolinates and their use as herbicides
04/26/2012US20120100628 Emissive and broadband nonlinear absorbing metal complexes and ligands as oled, optical switching or optical sensing materials
04/26/2012US20120100104 Antiviral Compounds And Uses Thereof
04/26/2012US20120097932 Condensed-cyclic compound, organic light-emitting diode comprising the same and flat panel display device comprising the organic light-emitting diode
04/26/2012US20120097925 Organic light-emitting device
04/26/2012US20120097899 Materials for organic electroluminescent devices
04/26/2012CA2815350A1 Piperidin-4-yl-azetidine diamides as monoacylglycerol lipase inhibitors
04/26/2012CA2815272A1 Novel substituted picolinic acids, salts and acid derivatives thereof, and use thereof as herbicides
04/26/2012CA2815142A1 1-(heterocyclic carbonyl)-2-substituted pyrrolidines
04/26/2012CA2815131A1 Substituted 6-amino-nicotinamides as kcnq2/3 modulators
04/26/2012CA2815114A1 1-(heterocyclic carbonyl) piperidines
04/26/2012CA2815107A1 Method for preparing substituted n-(3-amino-quinoxalin-2-yl)-sulfonamides and their intermediates n-(3-chloro-quinoxalin-2-yl)sulfonamides
04/26/2012CA2815105A1 N-benzyl heterocyclic carboxamides
04/26/2012CA2815055A1 Viral polymerase inhibitors
04/26/2012CA2814594A1 Tetrahydroquinoline derivatives used as ampk activators
04/26/2012CA2813994A1 Compounds, compositions and methods useful for cholesterol mobilisation
04/26/2012CA2813708A1 Arylamide derivatives as ttx-s blockers
04/26/2012CA2813162A1 Pyridine-2- derivatives as smoothened receptor modulators
04/26/2012CA2813063A1 Antagonist for mutated androgen receptor
04/25/2012EP2444398A2 Novel intermediates of voriconazole and preparation method of voriconazole using the same
04/25/2012EP2444395A1 Substituted isoquinoline derivative
04/25/2012EP2444392A1 (Aza)indole derivative substituted in position 5, pharmaceutical composition comprising it, intermediate compounds and preparation process therefor
04/25/2012EP2444085A1 Diarylhydantoin compounds as androgen receptor antagonists for treatment of cancer
04/25/2012EP2443104A1 Disubstituted phthalazine hedgehog pathway antagonists
04/25/2012EP2443096A1 Pyrazine carboxamides as inhibitors of dgat1
04/25/2012EP2443092A1 Bicyclic and tricyclic compounds as kat ii inhibitors
04/25/2012EP2443091A1 Anthelmintic agents and their use
04/25/2012EP2185507B1 Fungicide n-6-membered fused (hetero)aryl-methylene-n-cycloalkyl carboxamide derivatives
04/25/2012EP2129375B1 Imidazo[1,2-a]pyridines and their use as pharmaceuticals
04/25/2012EP2084147B1 Heterocyclic fxr binding compounds
04/25/2012EP2066656B1 5-substituted quinazolinone derivatives as antitumor agents
04/25/2012EP1858878B1 Conversion of 2-pyrazolines to pyrazoles using bromine
04/25/2012EP1824823B1 Process for the manufacture of 3-hydroxy-n-alkyl-1-cycloalkyl-6-alkyl-4-oxo-1,4-dihydropyridine-2-carboxamide and its related analogues
04/25/2012EP1804797B1 Use of a pyridine compound for the preparation of a medicament for the treatment of skin lesions
04/25/2012EP1745024B1 1-aryl-4-substituted isoquinolines
04/25/2012EP1565436B1 3-aminopyrrolidine derivatives as modulators of chemokine receptors
04/25/2012CN1863794B 作为血管生成抑制剂的喹唑啉衍生物 As angiogenesis inhibitors quinazoline derivative
04/25/2012CN102427853A Protease Inhibitors
04/25/2012CN102427813A Novel anti-inflammatory agents
04/25/2012CN102427810A 作为trpm8拮抗剂的氨磺酰基苯甲酸衍生物 As trpm8 antagonists sulfamoyl benzoic acid derivative
04/25/2012CN102424680A 病毒聚合酶抑制剂 Viral polymerase inhibitors
04/25/2012CN101899007B 哌嗪化合物 Piperazine compound
04/25/2012CN101495452B Ep2激动剂 Ep2 agonists
04/25/2012CN101006077B Crystalline form of a biphenyl compound
04/24/2012US8163936 Treatment of CRTH2-mediated diseases and conditions
04/24/2012US8163931 Treatment of CRTH2-mediated diseases and conditions
04/24/2012US8163926 Process for the synthesis of piperidinyl sulphonate esters